S. Borg, H. Nahi, M. Hansson, D. Lee, J. Elvidge, and U. Persson, “Cost effectiveness of pomalidomide in patients with relapsed and refractory multiple myeloma in Sweden”, AO, vol. 55, no. 5, pp. 554–560, May 2016.